Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation

Clinical trial NCT03702582 · COMPLETED

Trial details

NCT number: NCT03702582
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation Stroke Bleeding

Start date: 2019-04-30
Primary completion: 2023-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.